CL2007002837A1 - Uso de fenitoina para tratar mucositis oral. - Google Patents

Uso de fenitoina para tratar mucositis oral.

Info

Publication number
CL2007002837A1
CL2007002837A1 CL200702837A CL2007002837A CL2007002837A1 CL 2007002837 A1 CL2007002837 A1 CL 2007002837A1 CL 200702837 A CL200702837 A CL 200702837A CL 2007002837 A CL2007002837 A CL 2007002837A CL 2007002837 A1 CL2007002837 A1 CL 2007002837A1
Authority
CL
Chile
Prior art keywords
phenitoin
oral mucositis
treat oral
treat
mucositis
Prior art date
Application number
CL200702837A
Other languages
English (en)
Inventor
Bortz Jisheng Ge R Sa Jonathan
Original Assignee
Drugtech Corp Sa Organizada Ba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drugtech Corp Sa Organizada Ba filed Critical Drugtech Corp Sa Organizada Ba
Publication of CL2007002837A1 publication Critical patent/CL2007002837A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CL200702837A 2006-10-05 2007-10-02 Uso de fenitoina para tratar mucositis oral. CL2007002837A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82831906P 2006-10-05 2006-10-05

Publications (1)

Publication Number Publication Date
CL2007002837A1 true CL2007002837A1 (es) 2008-07-18

Family

ID=39322783

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200702837A CL2007002837A1 (es) 2006-10-05 2007-10-02 Uso de fenitoina para tratar mucositis oral.

Country Status (5)

Country Link
US (1) US20080299050A1 (es)
AR (1) AR063109A1 (es)
CL (1) CL2007002837A1 (es)
PE (1) PE20081114A1 (es)
WO (1) WO2008060764A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
WO2003103475A2 (en) 2002-06-07 2003-12-18 Dyax Corp. Prevention and reduction of blood loss
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
JP2005537006A (ja) 2002-08-28 2005-12-08 ダイアックス、コープ 臓器及び組織の保存方法
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
CA2744235A1 (en) 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
US8906883B2 (en) 2009-06-10 2014-12-09 Exthera Ab Treatment of oral mucositis by administering an ionic complex of chitosan and a negatively charged polysaccharide selected from heparin, heparan sulfate and dextran sulfate
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
EP3459564B1 (en) 2010-01-06 2021-10-27 Takeda Pharmaceutical Company Limited Plasma kallikrein binding proteins
CA2823776A1 (en) 2011-01-06 2012-07-12 Dyax Corp. Plasma kallikrein binding proteins
SMT202100228T1 (it) 2011-04-29 2021-05-07 Moberg Pharma Ab Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola
EP2874824B1 (en) 2012-07-23 2025-04-30 Crayola, LLC Dissolvable films and methods of using the same
EA201591755A1 (ru) * 2013-03-14 2016-03-31 3 ИН 1 ДЕНТАЛ ПиЭлЭлСи Композиции для лечения ксеростомии и для лечения зубов
US9433644B2 (en) 2013-07-25 2016-09-06 Rutgilli Pharmaceuticals, Llc Formulations and methods for treating oral inflammation, injury, or pain
WO2015101693A1 (es) * 2013-12-31 2015-07-09 Servicio Andaluz De Salud Composiciones y preparaciones combinadas para el tratamiento de las algias orofaríngeas
US11103546B2 (en) 2014-01-29 2021-08-31 Vita Ice Therapeutics Llc Edible oil compositions to treat oral complications and methods of using same
US9763934B2 (en) * 2014-03-05 2017-09-19 Professional Compounding Centers Of America Synergistic effect of poloxamer-based composition and itraconazole on fungus and yeast
IL295414B2 (en) 2014-03-27 2026-02-01 Takeda Pharmaceuticals Co Compositions and methods for treating macular edema due to diabetes
AU2016366557B2 (en) 2015-12-11 2024-01-25 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
US12528880B2 (en) 2020-01-13 2026-01-20 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589480A (en) * 1994-08-17 1996-12-31 Elkhoury; George F. Topical application of opioid analgesic drugs such as morphine
US6274168B1 (en) * 1999-02-23 2001-08-14 Mylan Pharmaceuticals Inc. Phenytoin sodium pharmaceutical compositions
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
US6906038B2 (en) * 2001-08-29 2005-06-14 Abbott Laboratories Methods for alleviating mucositis
WO2004005338A1 (en) * 2002-07-08 2004-01-15 Genova, Ltd. Secreted peptides

Also Published As

Publication number Publication date
WO2008060764A2 (en) 2008-05-22
PE20081114A1 (es) 2008-08-28
US20080299050A1 (en) 2008-12-04
AR063109A1 (es) 2008-12-30
WO2008060764A3 (en) 2008-07-24

Similar Documents

Publication Publication Date Title
CL2007002837A1 (es) Uso de fenitoina para tratar mucositis oral.
BRPI0810863A2 (pt) Uso de hidrolisados de proteína para estabilizar formulações de detergente de metaloprotease.
BRPI0807487A2 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
BRPI0908428A2 (pt) uso de ranozalina para tratar a dor.
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0912717A2 (pt) Composição farmacêutica, e, uso de 5-azacitidina
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
SMT201500206B (it) Composti spiro-ossindolici e loro uso come agenti terapeutici
BRPI0811635A2 (pt) Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos
BRPI0921433A2 (pt) uso de anticorpos anti-cs1 para o tratamento de linfomas raros
BRPI0816350A2 (pt) Composições orais, produtos e métodos de uso
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI0821668A2 (pt) Uso
CL2007003226A1 (es) Compuestos derivados de piridinona; composicion farmaceutica; y uso para tratar el cancer.
EP2092892A4 (en) ULTRASOUND DEVICE
BRPI0717411A2 (pt) Uso de inibidores de iap
BRPI0819821A2 (pt) Preparação e uso de polianilinas para tratamento de água
EP1984239A4 (en) DIVING SUIT WITH DOUBLE LAYER
BRPI0819188A2 (pt) Uso de melanocortinas para tratar sensibilidade à insulina.
CL2008000403A1 (es) Compuestos derivados de pentafluorotiobenzamido-acetonitrilo; composicion farmaceutica; y uso para tratar una infestacion por parasitos.
DOS2006000058S (es) Masticador para animales
BRPI0917552A2 (pt) kit para o tratamento de onicomicose
BRPI0812166A2 (pt) Composições úteis para reduzir nefrotoxicidade e métodos de uso das mesmas
PT1978981E (pt) Composições para uso vaginal
CO6210802A2 (es) Composicion de locion para uso personal